z-logo
Premium
Presence of B‐7.2 (CD86) and lack of B7‐1 (CD80) on myelin‐phagocytosing MHC‐II positive rat microglia are associated with nondestructive immunity in vivo
Author(s) -
Bechmann Ingo,
Peter Susanne,
Beyer Martin,
Gimsa Ulrike,
Nitsch Robert
Publication year - 2001
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fsb2fj000563fje
Subject(s) - microglia , experimental autoimmune encephalomyelitis , myelin , immunology , major histocompatibility complex , biology , multiple sclerosis , neuroscience , antigen , medicine , inflammation , central nervous system
Myelin‐associated epitopes are targets of destructive T‐cell responses during autoimmune diseases such as multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. However, autoimmune T cells do not respond in a destructive way to mechanically induced axonal degeneration despite myelin phagocytosis and presentation by local microglia. Using entorhinal cortex lesion, a model of axonal degeneration and reactive sprouting, we now show that myelin phagocytosing microglia up‐regulate MHC‐II and B7‐2 but lack expression of B7‐1, a costimulatory molecule related to destructive immunity. In zones of retrograde axonal degeneration, where axons undergo secondary damage and later contribute to the sprouting response, MHC‐II/B7‐2‐positive microglia are still found at 90 days postlesion. These cells exhibit the ramified morphology of resting microglia in the presence of CD4/B7‐2‐positive α/β T cells. Thus, in contrast to autoimmune brain disease, axonal degeneration lacks a signal to induce B7‐1 on microglial cells and the recruited T cells do not induce microglial activation. Differences in B7‐phenotype of local antigen presenting cells might provide an explanation for the important finding that autoimmune T cells elicit protective rather than destructive effects following axonal degeneration in the CNS.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here